Effect of angiotensin receptor blockade in the rabbit aorta: Influence of the endothelium

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 12, 1996, Pages 1277-1286

  Le Tran, Yen ^a   Forster, Christine ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiotensin receptors; Endothelium; Losartan; PD 123319; Rabbit aorta

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR; ENALAPRIL; LOSARTAN;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASOCONSTRICTION;

EID: 0030424002     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-129     Document Type: Article

References (54)

1. 1]angiotensin 1. Circ. Res. 41: 231-238.
2. Ahmad, S., and Ward, P.E. 1990. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J. Pharmacol. Exp. Ther. 252: 643-650.
3. Arunlakshana, O., and Schild, H.O. 1959. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14: 48-58.
4. Bohr, D.F. 1973. Angiotensin on vascular smooth muscle. In Handbook of experimental pharmacology. Springer Verlag, Berlin, pp. 424-440.
5. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension (Dallas), 26: 752-757.
6. Bumpus, F.M., Catt, K.J., Chiu, A.T., de Gasparo, M., Goodfriend, T., Husain, A., Peach, M.J., Taylor, D.G.J., and Timmermans, P.B.M.W.M. 1991. Nomenclature for angiotensin receptors: a report of the nomenclature committee of the Council for High Blood Pressure Research. Hypertension (Dallas), 17: 720-721.
7. Chen, L., McNeill, J.R., Wilson, T.W., and Gopalakrishnan, V. 1995. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin. Hypertension (Dallas), 26: 83-88.
8. Chiu, A.T., Carini, D.J., Johnson, A.L., McCall, A.T., Price, W.A., Thoolen, M.J.M.C., Wong, P.C., Taber, R.I., and Timmermans, P.B.M.W.M. 1988. Nonpeptide angiotensin II antagonists. II. 2-Butyl-4-chloro-1-(2-nitrobenzyl)imidazole-5-acetic acid, sodium salt (S-8308): a novel, competitive receptor antagonist specific for angiotensin II. Eur. J. Pharmacol. 157: 13-21.
9. Chiu, A.T., McCall, D.E., Price, W.A., Wong, P.C., Carini, D.J., Duncia, J.V., Wexler, R.R., Yoo, S.E., Johnson, A.L., and Timmermans, P.B.M.W.M. 1991. In vitro pharmacology of DuP 753, a nonpeptide AII receptor antagonist. Am. J. Hypertens. 4(Part2): 282S-287S.
10. Christen, Y., Waeber, B., Nusseberger, J., Porchet. M., Borland, R.M., Lee, R.J., Maggon, K., Shum, L., Timmermans, P.B.M.W.M., and Brunner, H.R. 1991. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers: inhibition of pressor response to exogenous angiotensin I and II. Circulation, 83: 1333-1342.
11. de Gasparo, M., Husain, A., Alexander W., Catt, K.J., Chiu, A.T., Drew, G.M., Goodfriend, T., Harding, J.W., Inagami, T., and Timmermans, P.B.M.W.M. 1995. Proposed update of angiotensin receptor nomenclature. Hypertension (Dallas), 25: 924-927.
12. Drummer, O.H., Kourtis, S., and Johnson, H. 1988. Formation of angiotensin II and other angiotensin peptides from des-Leu angiotensin I in rat lung and kidney. Biochem. Pharmacol. 37: 4327-4333.
13. 2) binding sites in R3T3 cells. Mol. Pharmacol. 40: 360-367.
14. Dzau, V.J. 1988. Evolving concepts of the renin-angiotensin system, focus on renal and vascular mechanisms. Am. J. Hypertens. 1: 3345-3375.
15. Emori, T., Hirata, Y., Ohta, K., Eguchi, S., Imai, T., Schichiri, M., and Marumo, F. 1991. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension (Dallas), 18: 165-170.
16. Fleming, W.W., Westfall, D.P., DeLaLande, I.S., and Jellet, L.B. 1972. Log-normal distribution of equieffective of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181: 339-345.
17. Forster, C. 1994. Does a functional endothelium modulate contractions of rabbit aorta to angiotensin II. Can. J. Physiol. Pharmacol. 72: P1.4.7. (Abstr.)
18. Forster, C. 1995. Endothelial modulation of angiotensin response in canine blood vessels. Br. J. Pharmacol. 116: 295P.
19. Forster, C., Larosa, G., and Armstrong, P.W. 1992. Impact of enalapril therapy on in vitro coronary artery responsiveness in pacing-induced heart failure. Can. J. Physiol. Pharmacol. 70: 1417-1422.
20. Gruetter, C.A., Ryan, E.T., and Schoepp, D.D. 1987. Endothelium enhances tachyphylaxis to angiotensin II and III in rat aorta. Eur. J. Pharmacol. 143: 139-142.
21. Gruetter, C.A., Ryan, E.T., Lemke, S.M., Bailly, D.A., Fox, M.K., and Schepp, D.D. 1988. Endothelium-dependent modulation of angiotensin Il-induced contraction in blood vessels. Eur. J. Pharmacol. 146: 85-95.
22. Hall, J.G., Mizelle, H.L., Brands, M.W., and Hildebrandt, D.A. 1992. Pressure natriuresis and angiotensin II in reduced kidney mass, salt-induced hypertension. Am. J. Physiol. 262: R61-R71.
23. Harberl, R.L., Anncser, F., Villringer, A., and Einhaupl, K.M. 1990. Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. Am. J. Physiol. 258: H1840-H1846.
24. Herlihy, J.T., and Berardo, P.V. 1986. Effect of preload on rat aortic smooth muscle sensitivity to vasoactive agents. Pharmacology, 6: 961-968.
25. Hollenberg, N.K. 1979. Pharmacologic interruption of the renin-angiotensin system. Annu. Rev. Pharmacol. Toxicol. 19: 559-582.
26. Jaiswal, N., Diz, D.I., Chappell, M.C., Khosla, M.C., and Ferrario, C.M. 1992. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. I. Characterization of receptors. Hypertension (Dallas), 19(Suppl. 2): II-49-II-55.
27. Jenkinson, D.H., Barnard, E.A., Hoyer, D., Humphrey, P.P.A., Leff, P., and Shankley, N.P. 1995. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev. 47: 255-266.
28. Li, Q., Zhang, J., Pfaffendorf, M., and van Zwieten, P.A. 1995. Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br. J. Pharmacol. 116: 2963-2970.
29. Moore, A.F., Hall, M.M., and Khairallah, P.A. 1976. A comparison of the effects of angiotensin II and heptapeptide on smooth muscle (vascular and uterine). Eur. J. Pharmacol. 39: 101-107.
30. Morton, J.J., Beattie, E.C., and MacPherson, F. 1992. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J. Vasc. Res. 29: 264-269.
31. Murphy, T.J., Nakamura, Y., Takeuchi, K., and Alexander, R.W. 1993. A cloned angiotensin isoform from the turkey adrenal gland is pharmacologically distinct from mammalian angiotensin receptors. Mol. Pharmacol. 44: 1-7.
32. Oshiro, M.E.M., Shimuta, S.I., Paiva, T.B., and Paiva, A.C.M. 1989. Evidence for a regulatory site in the angiotensin recptor of smooth muscle. Eur. J. Pharmacol. 166: 411-417.
33. Parker, R.B., and Waud, D.R. 1971. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J. Pharmacol. Exp. Ther. 177: 1-12.
34. Peach, M.J. 1977. Renin-angiotensin system: biochemistry and mechanism of action. Physiol. Rev. 57: 313-369.
35. Pendleton, R.G., Gessner, G., and Horner, E. 1991. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues. J. Pharmacol. Exp. Ther. 256: 614-620.
36. Pontieri, V., Lopes, U.I., and Ferreira, S.H. 1990. Hypertensive effect of captopril: role of bradykinin and prostaglandin-like substances. Hypertension (Dallas), 15(Suppl. 1): 155.
37. Reilly, C.F., Tewksbury, D.A., Schechter, N.M., and Travis, J. 1982. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mass cell proteases. J. Biol. Chem. 257: 8619-8622.
38. Rhaleb, N.E., Rouissi, N., Nantel, F., D'Orleans-Juste, P., and Regoli, D. 1991. DuP 753 is a specific antagonist for the angiotensin receptor. Hypertension (Dallas), 17: 480-484.
39. Robertson, M.J., Cunoosamy, M.P., and Clark, K.L. 1992. Effects of peptidase inhibition on angiotensin agonist and antagonist potency in rabbit isolated thoracic aorta. Br. J. Pharmacol. 106: 166-172.
40. Saye, J.A., Singer, H.A., and Peach, M.J. 1984. Role of the endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension (Dallas), 6: 216-221.
41. Scheuer, D.A., and Perrone, M.H. 1993. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am. J. Physiol. 264: R917-R923.
42. Seyedi, N., Xu, X.B., Nasjletti, A., and Hintze, T.H. 1995. Coronary kinin generation mediates nitric oxide release after anguiotensin receptor stimulation. Hypertension (Dallas), 26: 164-170.
43. Sim, M.K. 1993. Degradation of angiotensin I in the endothelium and smooth muscle of the rat aorta. Biochem. Pharmacol. 45: 1524-1527.
44. Streeten, D.H.P., and Anderson, G.H. 1984. Angiotensin receptor blocking drugs. In Handbook of hypertension. Vol. 5. Clinical pharmacology of antihypertensive drugs. Edited by A.E. Doyle. Elsevier, Amsterdam. pp. 246-271.
45. Timmermans, P.B.M.W.M., Carini, D.J., Chiu, A.T., Duncia, J.V., Price, W.A., Jr., Wells, G.J., Wong, P.C., Johnson, A.L., and Wexler, R.R. 1991. Nonpeptide angiotensin II receptor antagonists: a novel class of antihypertensive agents. Blood Vessels, 27: 295-300.
46. Timmermans, P.B.M.W.M., Wong, P.C., Chiu, A.T., Herblin, W.F., Benfield, P., Carini, D.J., Lee, R.J., Wexler, R.R., Saye, J.A.M., and Smith, R.D. 1993. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45: 205-251.
47. Toda, N., and Miyazaki, M. 1978. Regional and species differences in the response of isolated arteries to angiotensin II. Jpn. J. Pharmacol. 28: 495-497.
48. Toda, N., and Miyazaki, M. 1981. Angiotensin-induced relaxation in isolated dog renal and cerebral arteries. Am. J. Physiol. 240: H247-H254.
49. Tsutsumi, K., and Saavedra, J.M. 1991. Characterization of type-2 angiotensin II receptors in rat anterior cerebral arteries. Am. J. Physiol. 30: H667-H670.
50. 2+ dependency of angiotensin II-induced contractions of rat aortic rings. Fundam. Clin. Pharmacol. 7: 227-233.
51. Whitebread, S., Mele, M., Kamber, B., and De Gasparo, M. 1989. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163: 284-291.
52. Wienen, W., Diederen, W., Mauz, A.B.M., and van Meel, J.C.A. 1990. Reversal of the non-competitive behaviour of the angiotensin II antagonist in vitro and in vivo. Eur. J. Pharmacol. 183: 1553-1557.
53. Wong, P.C., Chiu, A.T., Price, W.A., Thoolen, M.J.M.C., Carini, D.J., Johnson, A.L., Taber, R.I., and Timmermans, P.B.M.W.M. 1988. Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl) imidazol-5-acetic acid, sodium salt (S-8307). J. Pharmacol. Exp. Ther. 247: 1-7.
54. Zhang, J.S., van Meel, J.C., Pfaffendorf, M., Zhang, J., and van Zwieten, P.A. 1994. Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta. Eur. J. Pharmacol. 262: 247-253.